Largest health care companies by earnings
Net income for the latest fiscal year: what was left for shareholders after every cost, interest and tax. A negative figure is a loss.
Johnson & Johnson leads the 170 health care companies ranked by earnings, at TRY 1.35T, ahead of Eli Lilly (TRY 1.04T) and Merck & Co (TRY 921.2B). Figures as of 19 Nov 2026, 11:14 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 170
- First
- Johnson & JohnsonTRY 1.35T
- Median
- TRY 13.7B
- Combined market value
- TRY 458.97T
- Countries
- 14
Market values as of .
All countries▾
Health Care▾
All categories▾
| # | Company | Earnings ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 101 | Hims & Hers HealthHIMS · Health Care | TRY 6.5B | TRY 201.7B | TRY 860.41 | 2.85% down | 51% down | ||
| 102 | Ligand PharmaceuticalsLGND · Health Care | TRY 6.3B | TRY 301.5B | TRY 15,074.04 | 1.67% up | 43% up | ||
| 103 | Corcept TherapeuticsCORT · Health Care | TRY 5B | TRY 374.4B | TRY 3,420.94 | 3.25% down | 8% down | ||
| 104 | HaemoneticsHAE · Health Care | TRY 4.9B | TRY 282.3B | TRY 6,199.98 | 1.60% up | 61% up | ||
| 105 | Amneal PharmaceuticalsAMRX · Health Care | TRY 3.6B | TRY 384.7B | TRY 1,104.15 | 3.60% up | 83% up | ||
| 106 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | TRY 3B | TRY 376.9B | TRY 4,796.58 | 0.06% down | 126% up | ||
| 107 | RepligenRGEN · Health Care | TRY 2.5B | TRY 557B | TRY 8,713.58 | 6.47% up | 5% up | ||
| 108 | LifeStance Health GroupLFST · Health Care | TRY 487.6M | TRY 264.2B | TRY 694.89 | 2.82% down | 129% up | ||
| 109 | BillionToOneBLLN · Health Care | TRY 376.2M | TRY 220.7B | TRY 4,619.46 | 6.11% down | 0% up | ||
| 110 | Arrowhead PharmaceuticalsARWR · Health Care | -TRY 82.3M | TRY 307.5B | TRY 2,175.49 | 0.28% up | 10% up | ||
| 111 | BrukerBRKR · Health Care | -TRY 434M | TRY 487.5B | TRY 3,192.34 | 3.10% up | 41% up | ||
| 112 | RadNetRDNT · Health Care | -TRY 941.3M | TRY 285.5B | TRY 3,624.31 | 4.14% down | 7% down | ||
| 113 | Mirum PharmaceuticalsMIRM · Health Care | -TRY 1.2B | TRY 304.7B | TRY 4,667.40 | 0.59% up | 31% up | ||
| 114 | Travere TherapeuticsTVTX · Health Care | -TRY 1.3B | TRY 243.4B | TRY 2,535.30 | 1.68% down | 44% up | ||
| 115 | 10x GenomicsTXG · Health Care | -TRY 2.2B | TRY 378.8B | TRY 2,879.97 | 1.37% up | 260% up | ||
| 116 | Adaptive BiotechnologiesADPT · Health Care | -TRY 3B | TRY 232.5B | TRY 1,436.20 | 0.11% down | 88% up | ||
| 117 | Caris Life SciencesCAI · Health Care | -TRY 3.4B | TRY 282.2B | TRY 984.04 | 2.21% down | 17% down | ||
| 118 | VeradermicsMANE · Health Care | -TRY 3.5B | TRY 265.9B | TRY 6,300.91 | 0.62% down | 233% up | ||
| 119 | Belite BioBLTE · Health Care | -TRY 3.9B | TRY 320.2B | TRY 7,883.96 | 0.94% down | 31% up | ||
| 120 | Twist BioscienceTWST · Health Care | -TRY 3.9B | TRY 400.3B | TRY 5,871.46 | 3.88% up | 340% up | ||
| 121 | Oruka TherapeuticsORKA · Health Care | -TRY 5.3B | TRY 327.7B | TRY 4,831.40 | 0.60% down | 241% up | ||
| 122 | HeartflowHTFL · Health Care | -TRY 5.9B | TRY 203.5B | TRY 2,315.78 | 2.51% down | 73% up | ||
| 123 | ErascaERAS · Health Care | -TRY 6.3B | TRY 243.7B | TRY 694.38 | 0.94% down | 403% up | ||
| 124 | Protagonist TherapeuticsPTGX · Health Care | -TRY 6.6B | TRY 418.8B | TRY 6,416.98 | 2.00% up | 46% up | ||
| 125 | Charles River Laboratories InternationalCRL · Health Care | -TRY 7.3B | TRY 805.8B | TRY 16,817.06 | 0.33% up | 105% up | ||
| 126 | Spyre TherapeuticsSYRE · Health Care | -TRY 7.8B | TRY 486.2B | TRY 5,120.06 | 8.15% up | 286% up | ||
| 127 | CG OncologyCGON · Health Care | -TRY 8.1B | TRY 360.6B | TRY 4,037.10 | 1.34% up | 85% up | ||
| 128 | Dianthus TherapeuticsDNTH · Health Care | -TRY 8.2B | TRY 238.7B | TRY 4,237.95 | 3.45% down | 113% up | ||
| 129 | Edgewise TherapeuticsEWTX · Health Care | -TRY 8.5B | TRY 228.6B | TRY 2,087.69 | 1.59% down | 88% up | ||
| 130 | Axsome TherapeuticsAXSM · Health Care | -TRY 9.2B | TRY 355.7B | TRY 6,762.15 | 1.43% down | 7% down | ||
| 131 | Definium TherapeuticsDFTX · Health Care | -TRY 9.3B | TRY 201.2B | TRY 1,469.51 | 0.88% down | 169% up | ||
| 132 | GlaukosGKOS · Health Care | -TRY 9.5B | TRY 696.3B | TRY 11,762.10 | 4.18% down | 152% up | ||
| 133 | Rhythm PharmaceuticalsRYTM · Health Care | -TRY 9.9B | TRY 416.5B | TRY 6,007.21 | 2.08% up | 13% up | ||
| 134 | NateraNTRA · Health Care | -TRY 10.5B | TRY 2.12T | TRY 14,609.27 | 0.71% up | 32% up | ||
| 135 | Kodiak SciencesKOD · Health Care | -TRY 11.6B | TRY 322.8B | TRY 4,935.86 | 1.04% up | 396% up | ||
| 136 | Elanco Animal HealthELAN · Health Care | -TRY 11.7B | TRY 673.5B | TRY 1,347.38 | 3.29% up | 20% up | ||
| 137 | LivaNovaLIVN · Health Care | -TRY 12.2B | TRY 262.8B | TRY 4,770.85 | 2.85% up | 71% up | ||
| 138 | Ascendis PharmaASND · Health Care | -TRY 12.8B | TRY 894.8B | TRY 13,641.88 | 0.32% down | 28% up | ||
| 139 | Madrigal PharmaceuticalsMDGL · Health Care | -TRY 14.5B | TRY 466.7B | TRY 20,088.63 | 5.67% down | 24% down | ||
| 140 | Legend BiotechLEGN · Health Care | -TRY 15B | TRY 159.1B | TRY 820.04 | 0.87% up | 42% down | ||
| 141 | Roivant SciencesROIV · Health Care | -TRY 15.1B | TRY 1.42T | TRY 1,954.46 | 0.05% up | 90% up | ||
| 142 | Praxis Precision MedicinesPRAX · Health Care | -TRY 15.3B | TRY 430.5B | TRY 15,401.05 | 0.04% up | 61% up | ||
| 143 | Kymera TherapeuticsKYMR · Health Care | -TRY 15.7B | TRY 521.8B | TRY 6,112.68 | 0.32% down | 87% up | ||
| 144 | Cogent BiosciencesCOGT · Health Care | -TRY 16.6B | TRY 244.2B | TRY 1,403.40 | 0.14% down | 20% down | ||
| 145 | MiniMed GroupMMED · Health Care | -TRY 16.8B | TRY 241.2B | TRY 857.38 | 4.44% down | 4% down | ||
| 146 | ImmunityBioIBRX · Health Care | -TRY 17.7B | TRY 359.7B | TRY 338.11 | 7.03% up | 193% up | ||
| 147 | Jazz PharmaceuticalsJAZZ · Health Care | -TRY 18B | TRY 802.6B | TRY 12,503.42 | 2.93% up | 37% up | ||
| 148 | Bausch + LombBLCO · Health Care | -TRY 18.2B | TRY 378B | TRY 1,057.22 | 0.58% up | 42% up | ||
| 149 | ABIVAXABVX · Health Care | -TRY 18.8B | TRY 370.3B | TRY 4,230.38 | 2.11% up | 27% down | ||
| 150 | Scholar Rock HoldingSRRK · Health Care | -TRY 19.1B | TRY 295.5B | TRY 2,422.26 | 6.48% up | 14% up | ||
| 151 | Ionis PharmaceuticalsIONS · Health Care | -TRY 19.2B | TRY 230.2B | TRY 1,382.20 | 1.59% up | 64% down | ||
| 152 | GRAILGRAL · Health Care | -TRY 20.6B | TRY 231.7B | TRY 5,152.35 | 3.57% down | 20% up | ||
| 153 | Guardant HealthGH · Health Care | -TRY 21B | TRY 990.9B | TRY 7,324.32 | 1.30% up | 44% up | ||
| 154 | Oscar HealthOSCR · Health Care | -TRY 22.4B | TRY 432.3B | TRY 1,391.29 | 7.61% down | 112% up | ||
| 155 | ImmunovantIMVT · Health Care | -TRY 25.5B | TRY 346.4B | TRY 1,673.88 | 0.12% down | 43% up | ||
| 156 | AvantorAVTR · Health Care | -TRY 26.8B | TRY 525.6B | TRY 775.63 | 1.25% up | 38% up | ||
| 157 | CRISPR TherapeuticsCRSP · Health Care | -TRY 29.3B | TRY 196.7B | TRY 2,028.14 | 0.10% up | 21% down | ||
| 158 | BridgeBio PharmaBBIO · Health Care | -TRY 37B | TRY 766.9B | TRY 3,936.68 | 1.58% up | 17% up | ||
| 159 | VaxcytePCVX · Health Care | -TRY 38.7B | TRY 467.5B | TRY 2,953.14 | 1.48% down | 22% up | ||
| 160 | CytokineticsCYTK · Health Care | -TRY 39.6B | TRY 360.8B | TRY 2,589.80 | 0.64% down | 20% down | ||
| 161 | TeleflexTFX · Health Care | -TRY 45.7B | TRY 331.9B | TRY 8,369.42 | 3.95% up | 51% up | ||
| 162 | Takeda PharmaceuticalTAK · Health Care | -TRY 48.2B | TRY 3.43T | TRY 1,073.37 | 1.71% down | 54% up | ||
| 163 | Baxter InternationalBAX · Health Care | -TRY 48.3B | TRY 683B | TRY 1,320.13 | 1.55% up | 46% up | ||
| 164 | Summit TherapeuticsSMMT · Health Care | -TRY 54.5B | TRY 423.8B | TRY 529.87 | 1.59% down | 36% down | ||
| 165 | Revolution MedicinesRVMD · Health Care | -TRY 57.1B | TRY 1.74T | TRY 8,065.12 | 1.76% down | 131% up | ||
| 166 | BioNTechBNTX · Health Care | -TRY 63.6B | TRY 1.04T | TRY 4,201.62 | 1.89% down | 16% down | ||
| 167 | InsmedINSM · Health Care | -TRY 64.4B | TRY 1.33T | TRY 6,045.56 | 1.69% down | 40% down | ||
| 168 | ModernaMRNA · Health Care | -TRY 142.4B | TRY 4.02T | TRY 9,930.77 | 4.84% down | 755% up | ||
| 169 | ViatrisVTRS · Health Care | -TRY 177.4B | TRY 1.17T | TRY 1,023.41 | 0.83% down | 96% up | ||
| 170 | CenteneCNC · Health Care | -TRY 336.8B | TRY 1.69T | TRY 3,403.78 | 7.03% down | 102% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Earnings is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 50.4638 TRY).
Questions and answers
Which health care companies rank first by earnings?
Johnson & Johnson (TRY 1.35T), Eli Lilly (TRY 1.04T) and Merck & Co (TRY 921.2B) are the top three of the 170 health care companies ranked by earnings as of 19 Nov 2026, 11:14 UTC.
How many health care companies are in this ranking?
170 are ranked by earnings.
What are these health care companies worth together?
The 170 health care companies ranked by earnings have a combined market value of TRY 458.97T as of 19 Nov 2026, 11:14 UTC.
What does ranking by earnings measure?
Net income for the latest fiscal year: what was left for shareholders after every cost, interest and tax. A negative figure is a loss.
Learn how this ranking works
All markets guides →- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
Cite this page
Funkfolio, “Largest health care companies by earnings”, data as of 19 November 2026. https://funkfolio.com/companies/sector/health-care?by=earnings
Underlying data: Yahoo Finance; SEC EDGAR.